204 related articles for article (PubMed ID: 20375178)
1. Urinary biomarkers for the early diagnosis of kidney cancer.
Morrissey JJ; London AN; Luo J; Kharasch ED
Mayo Clin Proc; 2010 May; 85(5):413-21. PubMed ID: 20375178
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
3. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
[TBL] [Abstract][Full Text] [Related]
4. Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.
Morrissey JJ; Mobley J; Song J; Vetter J; Luo J; Bhayani S; Figenshau RS; Kharasch ED
Urology; 2014 Jan; 83(1):256.e9-14. PubMed ID: 24239027
[TBL] [Abstract][Full Text] [Related]
5. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.
Morrissey JJ; Kharasch ED
J Urol; 2013 May; 189(5):1913-20. PubMed ID: 23154208
[TBL] [Abstract][Full Text] [Related]
6. Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin?
Grebe SK; Erickson LA
Mayo Clin Proc; 2010 May; 85(5):410-2. PubMed ID: 20435833
[No Abstract] [Full Text] [Related]
7. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
Dis Markers; 2014; 2014():135649. PubMed ID: 24803718
[TBL] [Abstract][Full Text] [Related]
8. Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management?
Song JB; Morrissey JJ; Mobley JM; Figenshau KG; Vetter JM; Bhayani SB; Kharasch ED; Figenshau RS
Int J Urol; 2019 Feb; 26(2):260-265. PubMed ID: 30467901
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
10. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma: Potential noninvasive biomarkers.
Mijugković M; Stanojević I; Milović N; Cerović S; Petrović D; Jovanović D; Aleksić P; Kovacević B; Andjelić T; Terzic B; Djukić M; Vojvodić D
Vojnosanit Pregl; 2016 Mar; 73(3):266-72. PubMed ID: 27295912
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive urine markers for the differentiation between RCCs and oncocytoma.
von Brandenstein M; Herden J; Köditz B; Huerta M; Nestler T; Heidenreich A; Fries JWU
J Clin Lab Anal; 2021 May; 35(5):e23762. PubMed ID: 33960011
[TBL] [Abstract][Full Text] [Related]
12. Can aquaporin-1 and adipophilin in urine distinguish between malignant and nonmalignant renal lesions?
Kramer MW; Merseburger AS; Tezval H
Mayo Clin Proc; 2010 Aug; 85(8):768; author reply 768-9. PubMed ID: 20675516
[No Abstract] [Full Text] [Related]
13. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
14. ARCHITECT® urine-neutrophil gelatinase-associated lipocalin (u-NGAL) assay as new prognostic marker for clear cell Renal Cell Carcinoma (ccRCC) (preliminary results).
Ben Khadhra H; Rose-Robert F; Herpe YE; Sevestre H; Choukroun G; Catherine L; Amant C; Saint F
Int Urol Nephrol; 2021 Jan; 53(1):59-67. PubMed ID: 32783115
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
Morrissey JJ; London AN; Lambert MC; Kharasch ED
Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
[TBL] [Abstract][Full Text] [Related]
16. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
Han WK; Alinani A; Wu CL; Michaelson D; Loda M; McGovern FJ; Thadhani R; Bonventre JV
J Am Soc Nephrol; 2005 Apr; 16(4):1126-34. PubMed ID: 15744000
[TBL] [Abstract][Full Text] [Related]
17. Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma.
Rini BI; Campbell SC
JAMA Oncol; 2015 May; 1(2):212-3. PubMed ID: 26181026
[No Abstract] [Full Text] [Related]
18. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
[TBL] [Abstract][Full Text] [Related]
20. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma.
Yao M; Huang Y; Shioi K; Hattori K; Murakami T; Nakaigawa N; Kishida T; Nagashima Y; Kubota Y
Clin Cancer Res; 2007 Jan; 13(1):152-60. PubMed ID: 17200350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]